Advertisement
Advertisement
U.S. Markets close in 1 hr 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Invitae Corporation (NVTA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.4950-0.0450 (-1.77%)
As of 02:16PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.5400
Open2.4600
Bid2.5000 x 4000
Ask2.5100 x 4000
Day's Range2.3300 - 2.5450
52 Week Range2.0800 - 34.2780
Volume5,546,610
Avg. Volume8,814,253
Market Cap564.796M
Beta (5Y Monthly)1.75
PE Ratio (TTM)N/A
EPS (TTM)-2.0490
Earnings DateFeb 15, 2022 - Feb 21, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.18
  • Zacks

    Signify (SGFY) Stock Jumps 6%: Will It Continue to Soar?

    Signify (SGFY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

  • Motley Fool

    Why Invitae Stock Plummeted by 15% Today

    Genetic medical testing specialist Invitae (NYSE: NVTA) didn't pass the investment test for one researcher late on Thursday. After market hours on Thursday, financial services company Piper Sandler initiated coverage of Invitae stock. "We think germline testing is becoming more commoditized and Invitae has a late start to somatic cancer," the prognosticator wrote in a research note, referring to two types of genetic screening for cancer.

  • TheStreet.com

    Why I Sold My Invitae Stock

    The genetic testing company has been unprofitable as it spent heavily (but that's only part of the story).

Advertisement
Advertisement